Tizanidine
Product Images NDC 50436-1180

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 50436-1180). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Fig1)

Description: This text provides a chart showing the plasma concentration of Tzanidine (in ng/mL) over time (in hours) after different dosing regimens of either 4 mg Tzanidine tablets or capsules with or without food. There is also a reference to a company or organization named "Eoiir Mamar RAS Nema" and "JRes! BN BA% Rak Gar azwaa", although the relevance of this information is unclear.*

FDA Label Image

Fig2 (Fig2)

FDA Label Image

Fig3 (Fig3)

The text describes an improvement in Ashworth Score due to Zanidine medication at a mean dose of 28.6 mg, observed at week 3 and at the end of maintenance endpoint (week 7, last observation carried forward).*

FDA Label Image

Label Image (Lbl504361180)

This is a medication label for Tizanidine Hydrochloride, which is a muscle relaxant used to treat muscle spasms and spasticity caused by conditions such as multiple sclerosis or spinal cord injuries. Each tablet contains 4mg of Tizanidine Hydrochloride. The label includes dosage information, storage instructions, and warnings to keep the medication out of reach of children. The lot number and expiration date are also provided.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.